The influence of CGS 16949A on peripheral aromatisation in breast cancer patients
Open Access
- 1 May 1991
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 63 (5) , 789-793
- https://doi.org/10.1038/bjc.1991.175
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Lack of diurnal variation in plasma levels of androstenedione, testosterone, estrone and estradiol in postmenopausal womenJournal of Steroid Biochemistry, 1989
- Alterations in the urine excretion of estrogen metabolites in breast cancer women treated with aminoglutethimideThe Journal of Steroid Biochemistry and Molecular Biology, 1989
- Alterations in the production rate and the metabolism of oestrone and oestrone sulphate in breast cancer patients treated with aminoglutethimideBritish Journal of Cancer, 1989
- Separation of urinary metabolites of radiolabelled estrogens in man by HPLCThe Journal of Steroid Biochemistry and Molecular Biology, 1989
- Mechanisms of Action of Aminoglutethimide as Endocrine Therapy of Breast CancerDrugs, 1988
- CGS-16949A, A NEW NONSTEROIDAL AROMATASE INHIBITOR - EFFECTS ON HORMONE-DEPENDENT AND HORMONE-INDEPENDENT TUMORS INVIVO1988
- In vitro and in vivo studies demonstrating potent and selective estrogen inhibition with the nonsteroidal aromatase inhibitor CGS 16949ASteroids, 1987
- Effective inhibition by low dose aminoglutethimide of peripheral aromatization in postmenopausal breast cancer patientsBritish Journal of Cancer, 1985
- Source of Estrogen Production in Postmenopausal Women1Journal of Clinical Endocrinology & Metabolism, 1973
- Estrone Sulfate: Production Rate and Metabolism in ManJournal of Clinical Investigation, 1972